EFFECT OF A PROGESTATIONAL AGENT ON ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL CANCER

W B Wentz, Wentz WB
Obstetrics and gynecology · 1964 · vol. 24 , pp. 370–5 · doi:10.1097/00006250-196409000-00007 · PMID:14207332
Other OA: closed public-domain-us
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-14 ⓘ

The provided text lacks an abstract and specific findings, preventing the generation of a summary regarding the effects of progestational agents on endometrial hyperplasia and cancer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antineoplastic Agents Antineoplastic Agents Drug Therapy Drug Therapy Endometrial Hyperplasia Endometrial Hyperplasia Endometrial Neoplasms Endometrial Neoplasms Endometriosis Endometriosis Neoplasm Metastasis Neoplasm Metastasis Progesterone Progesterone Progestins Progestins Uterine Neoplasms Uterine Neoplasms Female Female

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-01T09:25:17.647243+00:00
pubmed
last seen: 2026-10-08T21:01:56.755204+00:00
unpaywall
last seen: 2026-11-04T06:24:41.714486+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine